Global Cancer Observatory (GCO): An interactive web-based platform presenting global cancer statistics to inform cancer control and research.
Pan American Health Organization (PAHO) / World Health Organization (WHO): Access cervical cancer guides, manuals, and resources intended for healthcare professionals.
The cervical cancer screening and management guidelines outlined below are recommended by professional societies in the United States. Other countries are adopting and implementing guidelines according to their own developed policies and recommendations.
July 30, 2020 American Cancer Society Guidelines Update
Recommendations include an HPV test every five years for individuals with a cervix ages 25-65 as the preferred method of testing over the Pap test or the combination of Pap and HPV testing. Another significant change is for cervical cancer screening to begin at age 25. The previous ACS guideline, released in 2012, called for cervical cancer screening starting at age 21. https://acsjournals.onlinelibrary.wiley.com/doi/full/10.3322/caac.21628
The new guidelines reflect the rapidly changing landscape of cervical cancer prevention in the United States and around the world, focusing on better outcomes, test efficiency and more simplified screening. Human papillomavirus (HPV) is the cause of nearly all cervical cancers. Primary HPV testing every 5 years is more effective than Pap cytology alone for cervical cancer prevention, and more efficient than co-testing, reducing the number of tests while providing comparable outcomes.1,2
April 2, 2020—The ASCCP Risk Based Management Consensus Guidelines have now been published. Read here: https://journals.lww.com/jlgtd/pages/currenttoc.aspx?sessionEnd=true
ASCO Secondary Prevention of Cervical Cancer Resource-Stratified Guideline: https://www.asco.org/research-guidelines/quality-guidelines/guidelines/gynecologic-cancer#/14021 published in JGO DOI: 10.1200/JGO.2016.006577
US Preventive Services Task Force (USPSTF) Guidelines update August 21, 2018: https://www.uspreventiveservicestaskforce.org
American College of Obstetrics & Gynecology Practice Advisory update August 2018: https://www.acog.org/clinical/clinical-guidance/practice-advisory/articles/2018/08/cervical-cancer-screening-update
Society of Gynecologic Oncology (SGO): https://www.sgo.org/clinical-practice/guidelines/
American Cancer Society (ACS): https://www.cancer.org/cancer/cervical-cancer/detection-diagnosis-staging/cervical-cancer-screening-guidelines.html
Our patient website provides women with educational information about cervical cancer prevention and HPV screening, along with support resources. Patients can find cervical cancer patient videos and stories to help them know they’re not alone. We also have a great Facebook community where patients can find information about HPV and cervical cancer, and also connect with others who might be having, or have had, similar experiences.
With today's scientific advancements and our current understanding of the science behind HPV, we no longer believe that the status quo in cervical screening is good enough. Roche continues to make significant investment in screening strategies, product development, and clinical study evidence, because we know that you expect this and that women deserve more.
The Roche cervical cancer portfolio is unique in that it supports women along a continuum of care, enabling physicians to screen and diagnose disease, before invasive cancer ever develops. We help laboratories and clinicians by providing additional information about a patient's risk so that her care is more individualized, and there is evidence behind important treatment decisions. Giving a woman the right care at the right time will not only help protect her from the progression of disease, but can also help protect her from the risk or over- or under-treatment.
Many published articles and papers support the advancement of science around HPV and cervical cancer prevention. The science behind HPV and its role in disease progression has opened up new pathways for patient management and care. Please see below for a summary of clinical study publications that have been significant in shaping and supporting today's understanding to guide clinical practice.